<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Analysis of proliferation and apoptotic induction by 20 steroid glycosides in 143B osteosarcoma cells in vitro</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Delebinski</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Paediatric Oncology/Haematology</orgName>
								<orgName type="institution">Otto-Heubner-Centre for Paediatric and Adolescent Medicine (OHC)</orgName>
								<address>
									<addrLine>Charit e</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institute for Pharmacy</orgName>
								<orgName type="institution">Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>†FU Berlin</addrLine>
									<postCode>13353, 14195</postCode>
									<settlement>Berlin, Germany, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Georgi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Kleinsimon</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Paediatric Oncology/Haematology</orgName>
								<orgName type="institution">Otto-Heubner-Centre for Paediatric and Adolescent Medicine (OHC)</orgName>
								<address>
									<addrLine>Charit e</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institute for Pharmacy</orgName>
								<orgName type="institution">Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>†FU Berlin</addrLine>
									<postCode>13353, 14195</postCode>
									<settlement>Berlin, Germany, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Twardziok</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Paediatric Oncology/Haematology</orgName>
								<orgName type="institution">Otto-Heubner-Centre for Paediatric and Adolescent Medicine (OHC)</orgName>
								<address>
									<addrLine>Charit e</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institute for Pharmacy</orgName>
								<orgName type="institution">Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>†FU Berlin</addrLine>
									<postCode>13353, 14195</postCode>
									<settlement>Berlin, Germany, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Kopp</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Melzig</surname></persName>
						</author>
						<author role="corresp">
							<persName><forename type="first">G</forename><surname>Seifert</surname></persName>
							<email>georg.seifert@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Paediatric Oncology/Haematology</orgName>
								<orgName type="institution">Otto-Heubner-Centre for Paediatric and Adolescent Medicine (OHC)</orgName>
								<address>
									<addrLine>Charit e</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institute for Pharmacy</orgName>
								<orgName type="institution">Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>†FU Berlin</addrLine>
									<postCode>13353, 14195</postCode>
									<settlement>Berlin, Germany, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">‡Department of Pharmacognosy</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<postCode>A-1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">Department of Paediatric Oncology/Hae-matology</orgName>
								<orgName type="institution" key="instit1">Charit e -Universitaetsmedizin Berlin</orgName>
								<orgName type="institution" key="instit2">Otto Heubner Centre for Paediatric and Adolescent Medicine (OHC)</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Analysis of proliferation and apoptotic induction by 20 steroid glycosides in 143B osteosarcoma cells in vitro</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">64D16552561BF241CD227DE7FE181C1C</idno>
					<idno type="DOI">10.1111/cpr.12208</idno>
					<note type="submission">Received 28 April 2015; revision accepted 4 July 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:37+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Objectives: Osteosarcoma is the most common type of malignant bone tumour in children and adolescents; it has poor prognosis, is highly metastatic and is resistant to current therapeutic approaches.</s><s>In this study, different herbal extracts used in phytotherapy have been screened after searching innovative natural anti-cancer components.</s><s>Materials and methods: Twenty steroid glycosides were examined for accordance to their potential of inhibiting cell proliferation and inducing apoptosis in the osteosarcoma cell line 143B.</s><s>Cell proliferation was examined using a CASY counter.</s><s>Effects of cardiac glycosides on induction of apoptosis were evaluated by Annexin V-APC and flow cytometry, caspase activity assay and measurement of mitochondrial membrane potential.</s></p><p><s>Results: The study revealed that various steroid glycosides suppress cell proliferation in a concentration-dependent manner.</s><s>Further investigations indicated apoptotic induction by 17 of the 20 tested cardenolides and bufadienolides.</s><s>Bufadienolide proscillaridin A, arenobufagin, and cardenolides evomonoside, convallatoxol and ouabain waged strongest apoptotic induction, associated with breakdown of mitochondrial membrane potential and activation of caspases -8 and -9.</s><s>In contrast, the bufadienolide resibufogenin and cardenolide uzarin had no effect on proliferation inhibition, apoptotic induction or change in mitochondrial membrane potential.</s><s>Conclusion: These results indicate that bufadienolides proscillaridin A and arenobufagin and cardenolide evomonoside, or related natural compounds might be promising new starting points for development of novel anti-cancer agents for treatment of osteosarcoma.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Osteosarcoma is the most common primary malignant bone tumour, mainly occurring in children and adolescents <ref type="bibr" target="#b0">(1)</ref>.</s><s>The most challenging problem facing orthopaedic oncologists is to counter multidrug resistance (MDR) induced by classic chemotherapeutic agents such as methotrexate, adriamycin and cisplatin.</s><s>In the order of 50% of osteosarcoma cases are resistant to chemotherapy or acquire resistance during treatment <ref type="bibr" target="#b1">(2,</ref><ref type="bibr" target="#b2">3)</ref>.</s><s>Thus, there is great need for exploring mechanisms of chemotherapeutic resistance and developing new or additional treatment regimens for chemotherapy-resistant osteosarcoma.</s><s>Novel strategies in cancer therapy based on steroid glycosides are discussed as possibilities for counteracting multidrug resistance by using cardiac glycosides.</s></p><p><s>Steroid glycosides have been used in the treatment of congestive heart failure, arrhythmia <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b4">5)</ref> and malignant diseases in the past <ref type="bibr" target="#b5">(6,</ref><ref type="bibr" target="#b6">7)</ref>.</s><s>They are a category of compounds isolated from plants or animals (mainly bufo) from which their names have originated <ref type="bibr" target="#b7">(8)</ref>.</s><s>Chemically, they can be categorized into two groups.</s><s>On the one hand are the cardenolides, characterized by having an unsaturated butyrolactone ring of five members at C-17, plus C-23 steroids, and on the other hand the bufadienolides, which have a six-membered double unsaturated pyrone ring <ref type="bibr" target="#b8">(9)</ref>.</s><s>Both groups are able to bind to and inhibit the Na + /K + -ATPase pump, which results in activation of different signal cascades involved in the mechanism of proliferation, induction of apoptosis or gene expression <ref type="bibr" target="#b9">(10)</ref><ref type="bibr" target="#b10">(11)</ref><ref type="bibr" target="#b11">(12)</ref><ref type="bibr" target="#b12">(13)</ref><ref type="bibr" target="#b13">(14)</ref><ref type="bibr" target="#b14">(15)</ref>.</s><s>For example, for 19-hydroxy-2-oxovoruscharine anti-cancer activity in chemosensitive versus MDR, cancer and apoptosis-resistant cells, has been described <ref type="bibr" target="#b15">(16)</ref><ref type="bibr" target="#b16">(17)</ref><ref type="bibr" target="#b17">(18)</ref>.</s></p><p><s>However, over the few last decades, several studies have demonstrated anti-cancer properties of different steroid glycosides, for example digoxin and ouabain in human breast cancer cell lines <ref type="bibr" target="#b18">(19,</ref><ref type="bibr" target="#b19">20)</ref>.</s><s>McConkey et al. demonstrated apoptotic induction by steroid glycosides such as oleandrin, ouabain and digoxin in human prostate cancer cell lines in vitro <ref type="bibr" target="#b13">(14)</ref>.</s><s>Digoxin and digitoxin have already been reported in clinical studies to afford therapeutic effectiveness in breast cancer and prostate cancers and leukaemia <ref type="bibr" target="#b20">(21)</ref><ref type="bibr" target="#b21">(22)</ref><ref type="bibr" target="#b22">(23)</ref>.</s><s>For ouabain and digoxin, apoptotic induction has been described in human acute T-cell lines <ref type="bibr" target="#b23">(24,</ref><ref type="bibr" target="#b24">25)</ref>.</s><s>Lopez-Lazaro et al. reported that digitoxin inhibited cell proliferation in cancer cell lines at concentrations commonly found in the plasma of cardiac patients <ref type="bibr" target="#b25">(26)</ref>.</s><s>Of the bufadienolides, bufalin and cinobufagin, an anti-proliferative effect and anti-cancer properties in prostate cancer and human hepatocellular carcinoma cells have already been published <ref type="bibr" target="#b26">(27,</ref><ref type="bibr" target="#b27">28)</ref>.</s></p><p><s>The aim of this study was to analyse growth inhibitory effect and induction of apoptosis in 20 structurally different steroid glycosides, in the 143B osteosarcoma cell line, hopefully to discover new agents to negotiate a way around multidrug resistance.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Steroid glycosides</head><p><s>A library of cardioactive steroids was obtained from Prof. Brigitte Kopp (Department of Pharmacognosy, University of Vienna, Austria).</s><s>Their purities were &gt;95% determined by HPLC/UV analysis.</s><s>The cardenolides desglucocheirotoxin, strophanolloside, lokundjoside, convallatoxol and the bufadienolide proscillaridin A as well as the bufadienolide aglycons arenobufagin, resibufogenin, bufarenogin, bovogenin A, gamabufogenin, bufotaline and the cardenolide evomonoside, were isolated from Convallaria majalis L. toad venoms and Urginea species.</s><s>Their chemical structures were elucidated by NMR spectroscopy and mass spectrometry (MS) as described in more detail previously <ref type="bibr" target="#b28">(29)</ref><ref type="bibr" target="#b29">(30)</ref><ref type="bibr" target="#b30">(31)</ref><ref type="bibr" target="#b31">(32)</ref><ref type="bibr" target="#b32">(33)</ref><ref type="bibr" target="#b33">(34)</ref><ref type="bibr" target="#b34">(35)</ref>.</s></p><p><s>Cardenolides digitoxin, gitoxin, lanatosid C, digoxin, ouabain, k-strophanthin and helveticoside were purchased from Sigma-Aldrich (Munich, Germany) and uzarin was provided by ChromaDex (Irvine, CA, USA).</s></p><p><s>Ouabain, k-strophanthin, uzarin and helveticoside were dissolved in phosphate-buffered saline (PBS, Gibco Life technologies, Darmstadt, Germany) to constitute 5 mM stock solutions, and stored at room temperature.</s><s>Remaining substances were dissolved in DMSO from Sigma-Aldrich for stock solutions (5 mM).</s><s>Bufarenogin, uzarin and resibufogenin stock solutions were diluted in PBS to a final concentration of 100 lM, the remaining substances to a 20 lM/PBS working solution, before use.</s><s>Highest DMSO concentration did not exceed 0.04 % (v/v).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture</head><p><s>Human 143B and U-2OS osteosarcoma cell lines were obtained from the ATCC (American Type Culture Collection, Rockwille, MD, USA).</s><s>143B was cultured in RPMI 1640 medium, and U-2OS in McCoys medium supplemented with 10% heat inactivated foetal calf serum (Biochrom, Berlin, Germany), 100 U/ml penicillin and 100 lg/ml streptomycin at 37 °C and 5% CO 2 .</s><s>Both cell lines were transferred to six-well plates at 4 9 10 5 /well 18 h before assay set-up.</s><s>Cells were treated at indicated concentrations and duration with different cardiac glycosides, and then subjected to analysis.</s><s>RPMI 1640 and McCoys medium base and penicillin/streptomycin stock solution were purchased from Gibco, Life Technologies.</s></p><p><s>Effects of cardiac glycosides on cell viability were measured after 4 h using a Cytotoxicity Detection Kit Plus (Roche, Grenzach-Wyhlen, Germany) that quantifies lactate dehydrogenase (LDH) release, according to the manufacturer's protocol.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Propidium iodide and annexin V binding assay</head><p><s>Cells were incubated for 24 h with described cardiac glycosides and concentrations.</s><s>After incubation, apoptotic level was analysed as described previously <ref type="bibr" target="#b29">(30)</ref>.</s><s>Results were evaluated with FlowJo Software (TreeStar, Ashland, OR, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analysis of mitochondrial membrane potential (ΔΨm)</head><p><s>Mitochondrial membrane potential was assessed using 5,5,6,6-tetrachloro-1,1,3,3-tetraethylbenzimidazol-carbocyanine iodide (JC-1, Sigma-Aldrich) and flow cytometric analysis, as described previously <ref type="bibr" target="#b35">(36)</ref>.</s><s>Cells were analysed after 24 h incubation or depicted time points.</s><s>Depolarizing carbonyl cyanide 3-chlorophenylhydrazone (CCCP; Sigma-Aldrich) was used as reference, cells being treated with 50 lM CCCP (final concentration) for 30 min.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measurement of caspase activity</head><p><s>Activity of caspases -8 and -9 was measured by fluorescent caspase staining kit according to the manufacturer's protocol (Promokine, Heidelberg, Germany).</s><s>For caspase inhibitor assay, cells were pre-incubated with 100 lM z-VAD-fmk for 1 h.</s><s>After additional incubation with depicted cardiac glycosides for 24 h, induction of apoptosis was determined using annexin V-APC/PI with FACS analyses.</s><s>DMSO was added to extracts as solvent control.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analyses</head><p><s>Student's t-test was applied to determine differences between glycoside-treated cells and controls and significance level was set at P ≤ 0.05 for all tests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Steroid glycosides affected proliferation of 143B cells</head><p><s>Anti-proliferative effect of 20 steroid glycosides (Table <ref type="table" target="#tab_0">1</ref>) was evaluated using the CASY © Counter system, after incubation with increasing concentrations of reagents (range 0.05-1 lM) for 24 h.</s><s>Cell population growth was inhibited in a dose-dependent manner in 17 of the 20 steroid glycoside-treated cells (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s>Classical digitalis glycosides ouabain and digitoxin, were able to inhibit cell proliferation within a range of 0.1-0.15</s><s>lM (50% cell population growth inhibition).</s><s>Data in Fig. <ref type="figure" target="#fig_0">1</ref> demonstrate that most efficient anti-proliferative effect was obtained by cardenolides convallatoxol and evomonoside and bufadienolide proscillaridin A, as well as ouabain and bufadienolide aglycon arenobufagin A. In contrast, neither uzarin nor resibufagenin altered cell proliferation after 24 h incubation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Steroid glycosides induced apoptosis in a concentrationdependent manner</head><p><s>To assess possible effects of steroid glycosides on apoptotic induction, 143B cells were incubated with increasing doses of identical steroid glycosides as used before.</s><s>Figure <ref type="figure" target="#fig_1">2</ref> displays apoptotic induction after 24 h.</s><s>Glycosides evomonoside, ouabain and arenobufagenin caused 50% apoptotic induction in a range of 0.05-0.15</s><s>lM, whereas bufotalin, bovogenin A, lokundjoside, desglucocheirotoxin and strophanallosid induced 50% apoptosis in a range of 0.2-1 lM.</s><s>Treatment with bufadienolide proscillaridin A showed strongest apoptotic effect between 0.05 and 0.1 lM.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Steroid glycosides induced apoptosis via the mitochondrial pathway</head><p><s>To determine whether apoptotic induction by the most effective cardiac glycosides (IC50 range between 0.05 and 0.2 lM) was attributable to breakdown of mitochondrial membrane potential (DΨm/MMP), cells were incubated under the same conditions as before and analysed after JC-1 staining, by flow cytometry.</s><s>Data in Fig. <ref type="figure" target="#fig_2">3</ref> reveal dosedependent breakdown of DΨm for all tested substances.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Time-dependent analysis of apoptotic induction by the most potent substances, evomonoside, proscillaridin A and arenobufagin</head><p><s>Next, level of apoptosis and breakdown of MMP were analysed at different time points for the three most effective glycosides (proscillaridin A, arenobufagin, evomonoside).</s><s>Data in Fig. <ref type="figure" target="#fig_3">4</ref> reveal that drug-induced apoptosis occurred after 6 h and that there was no significant difference in apoptotic level and loss of mitochondrial membrane potential between 16 and 24 h.</s><s>To exclude unwanted cytotoxic effects such as necrosis, LDH release was measured after 4 h incubation with proscillaridin A, arenobufagin and evomonoside.</s><s>As shown in Fig. <ref type="figure" target="#fig_3">4b</ref>, no significant LDH release was measurable for different doses of the three tested drugs.</s><s>Furthermore, effectiveness of proscillaridin, evomonoside and arenobufagin was analysed in a secondary osteosarcoma cell line U-2OS.</s><s>In that, these glycosides were also able to induce apoptosis in a concentration-dependent manner accompanied by loss of DΨm (Fig. <ref type="figure" target="#fig_0">S1</ref>), but were less sensitive to the glycosides than line 143B.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cardiac glycosides affected caspase activity of both intrinsic and extrinsic apoptotic pathways</head><p><s>For further characterization of the molecular pathways involved in apoptosis, activation of caspases -8 and -9 were assessed in 143B cells.</s><s>Both caspases are upstream initiator proteases, which play key roles in the extrinsic (caspase-8) or the intrinsic (caspase-9) apoptotic pathway.</s><s>Data in Fig. <ref type="figure" target="#fig_4">5a</ref> reveal similar activation of both caspases by proscillaridin, evomonoside and arenobufagin in a concentration-dependent manner.</s></p><p><s>To analyse the role of caspases, 143B cells were treated in the absence or presence of the broad range caspase inhibitor z-VAD-fmk.</s><s>In all three treated cell types, z-VAD-fmk treatment reduced apoptotic induction between 30% and 40%.</s><s>These results indicate that both extrinsic and intrinsic signalling pathways play a role in cardiac glycosideinduced apoptosis in osteosarcoma in vitro.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Previous studies have shown anti-proliferative and antitumour properties for some analysed steroid glycosides in various cancer cell lines, although little has been known concerning their effects on osteosarcoma cells.</s><s>To our knowledge, this is the first time that an anti-proliferative effect and apoptotic induction have been analysed for evomonoside, convallatoxol, lokundjoside, desglucocheirotoxin and strophanolloside in cancer cells.</s><s>These five cardenolides have the ability to inhibit cell proliferation and exert induction of apoptosis in a  concentration range in the order of 0.080-1 lM.</s><s>Here, evomonoside had the strongest effect within 0.08-0.15</s><s>lM.</s><s>In the literature, we found no data to be available on an anti-cancer effect of this cardenolide.</s></p><p><s>By comparison of all 20 steroid glycosides analysed here, the bufadienolide proscillaridin A displayed the strongest effect in causing apoptosis and inhibition of cell proliferation.</s><s>Johansson et al. have shown apoptotic induction in 9 of 10 analysed human cancer cell lines at concentration of 0.06 -0.67 lM (37).</s><s>In our study, concentration ranged between 0.05 and 0.1 lM.</s><s>Bielawski et al. demonstrated an anti-proliferative effects of proscillaridin A, digitoxin and ouabain at nanomolar drug concentrations, whereas proscillaridin A was much more effective at lower concentrations (0.03 lM for proscillaridin A, 0.1 lM for digitoxin and ouabain) in breast cancer cells <ref type="bibr" target="#b37">(38)</ref>.</s><s>In glioblastoma, proscillaridin A causes cytotoxicity in vitro (IC50 2-4 nM), reduces tumour weight and improves survival of tumour bearing mice in vivo <ref type="bibr" target="#b38">(39)</ref>.</s><s>Recent studies by Cerella et al. have validated Mcl-1 as a common target of cardenolides <ref type="bibr" target="#b39">(40)</ref>, with down-regulation of Mcl-1 before apoptotic induction in U937 cells, not only for the hemi-synthetic cardenolide UNBS1450 but also for proscillaridin, oubain, digoxin and digitoxin.</s><s>These data are consistent with the results obtained by other groups at the level of protein expression under requirement of proteasome degradation <ref type="bibr" target="#b40">(41,</ref><ref type="bibr" target="#b41">42)</ref>.</s></p><p><s>Anti-proliferative effects of 27 bufadienolides have been reported in six human and two mouse cancer cell lines in comparison to ouabain and digoxin.</s><s>Moreno et al. showed that several bufadienolides, for example gamabufotalin rhamnoside (2-8 nM), bufotalin (9-74 nM) and hellebrin (7-68 nM), displayed higher rates of proliferation inhibition than digoxin (40-266 nM) and ouabain (28-211 nm) after 3 days culture <ref type="bibr" target="#b31">(32)</ref>.</s></p><p><s>In our study, strongest effect in cell population growth inhibition and apoptotic induction among the group of cardiac glycosides, was observed for the common cardiac glycosides ouabain &gt; digitoxin &gt; digoxin &gt; k-strophantin.</s><s>For these glycosides, apoptotic level has been shown in vitro and in vivo <ref type="bibr" target="#b42">(43,</ref><ref type="bibr" target="#b43">44)</ref>.</s></p><p><s>For the cardiotonic steroid ouabain, an anti-proliferative effect was observed, at the very high concentrations of 1-10 lM, in three different prostate and breast cancer and leukaemia cell lines <ref type="bibr" target="#b19">(20,</ref><ref type="bibr" target="#b44">45)</ref>.</s><s>Moreover, activity of caspases -3 and -9 was described in HeLa, neuroblastoma SH-SY5Y and human fibroblasts <ref type="bibr" target="#b45">(46)</ref>.</s><s>Furthermore, ouabain triggered cytochrome c release from mitochondria in neuroblastoma and HeLa cells in correlation with down-regulation of anti-apoptotic proteins Bcl-2 and Bcl-XL <ref type="bibr" target="#b42">(43,</ref><ref type="bibr" target="#b45">46)</ref>.</s><s>Recent studies have proposed caspase-independent autophagic cell death via JNK activation and Bcl-2 reduction, for oubain, in non-small cell lung cancer (concentration 50-100 nM) (44).</s><s>Pezzani et al. were able to show an anti-proliferative effect in adrenocortical cell lines, whereas concentrations from 1 to 1000 nM did not induce apoptosis after 24 h (47).</s><s>In our study, we observed both inhibition of cell population growth and induction of apoptosis, at clearly lower concentrations than described previously.</s><s>Overall, these data indicate that the ouabain-induced apoptotic mechanism might be dependent on the particular cancer under consideration.</s><s>Hiyoshi et al. have reported that ouabain significantly reduced tumour growth in a xenografted neuroblastoma mouse model in vivo without significant toxicity to the host <ref type="bibr" target="#b47">(48)</ref>.</s><s>These data were confirmed by two other groups with an AML and prostate cancer xenograft mouse models <ref type="bibr" target="#b48">(49,</ref><ref type="bibr" target="#b49">50)</ref>.</s></p><p><s>For digitoxin, Stenkvist et al. reported epidemiological studies in which women with breast cancer on digitalis therapy developed more benign forms of breast tumour and succumbed to levels death (6%) compared to control patients <ref type="bibr" target="#b50">(51)</ref><ref type="bibr" target="#b51">(52)</ref><ref type="bibr" target="#b52">(53)</ref>.</s><s>Furthermore, the recurrence rate of patients with digitalis treatment was 9.6-times lower than that of control patients.</s></p><p><s>Within the group of bufadienolide aglycons in our study, arenobufagin A was the most effective glycoside.</s><s>Effectiveness of bufadienolide aglycons in order of rank are: arenobufagin A &gt;gamabufotalin &gt; bufotalin &gt; bovogenin A. Arenobufagin A is listed as a key cardiotonic steroid of toad venom, but only a small number of studies on arenobufagin and cancer, seem to have been published.</s><s>We observed induction of apoptosis, accompanied by loss of mitochondrial membrane potential and activation of caspases -8 and -9, between 0.1 and 0.2 lM of arenobufagin A. Additionally, arenobufagin A markedly inhibited population growth of 143B cells.</s><s>In accord with our results, Zhang et al. reported for the first time that arenobufagin A induced apoptosis via caspase 3-and -9 activation and autophagy through inhibition of the phosphatidyl inositol 3-kinase (PI3K)/ Akt/mammalian target of rapamycin (mTOR) pathway in hepatocellular carcinoma (HCC) cells, in a concentration range between 0.2 and 0.5 lM <ref type="bibr" target="#b53">(54)</ref>.</s><s>Moreover it has been reported that arenobufagin is able to block the Na + /K + -ATPase pump <ref type="bibr" target="#b54">(55)</ref> and vascular endothelial growth factor-mediated angiogenesis, in several human cancer cell lines, in vitro and in vivo <ref type="bibr" target="#b55">(56)</ref>.</s></p><p><s>The bufadienolide bufalin was the first identified bufadienolide to be analysed as a potential agent in different osteosarcoma cell lines in vitro and in vivo <ref type="bibr" target="#b56">(57)</ref><ref type="bibr" target="#b57">(58)</ref><ref type="bibr" target="#b58">(59)</ref><ref type="bibr" target="#b59">(60)</ref><ref type="bibr" target="#b60">(61)</ref><ref type="bibr" target="#b61">(62)</ref>.</s><s>Xie et al. demonstrated strong inhibition of tumour growth in a methotrexate-resistant cancer model in vivo, without reduction in host body weight <ref type="bibr" target="#b62">(63)</ref>.</s><s>Other studies have shown caspase-independent apoptotic induction with involvement of autophagy-mediated cell death and JNK activation, after bufalin treatment <ref type="bibr" target="#b63">(64,</ref><ref type="bibr" target="#b64">65)</ref>.</s></p><p><s>Mechanisms of cardiac glycoside activity in cardiac disease treatment, with involvement of Na + /K + -ATPase are well characterized, whereas less is known regarding mechanisms of their anti-cancer effects.</s><s>Correlation between binding to Na + /K + -ATPase and apoptotic induction plays an important role in the question of anticancer mechanisms.</s><s>Binding to Na + /K + -ATPase leads to inhibition of ATPase, increase in intracellular Na + and Ca 2+ , intracellular reduction in K + and inhibition of IL-8 production and the TNF-a/NF-KB pathway.</s><s>Furthermore, DNA topoisomerase II was found to have been inhibited and the Src kinase pathway was activated <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b65">66,</ref><ref type="bibr" target="#b66">67)</ref>.</s><s>For digitoxin, it has already been described that apoptotic induction is connected to inhibition of Na + /K + -ATPase and increase in intracellular Ca 2+ <ref type="bibr" target="#b13">(14,</ref><ref type="bibr" target="#b67">68)</ref>.</s><s>For human lung adenocarcinoma, anti-cancer effects of ouabain have been reported to regulate and inactivate Src-toezrin signalling, Na + /K + -ATPase subunits and proteins involved in focal adhesion <ref type="bibr" target="#b68">(69)</ref>.</s><s>However, Akimova et al. reported that ouabain and other cardiac glycosides induced apoptosis in vascular endothelial cells and renal epithelial cells, Na + /K + independently <ref type="bibr" target="#b69">(70,</ref><ref type="bibr" target="#b70">71)</ref>.</s><s>One explanation for the different potency of apoptotic induction by the investigated steroidal glycosides could be different affinity to a Na + /K + -ATPase a-subunit, which is not primarily involved in ion efflux but in signal transduction, within the process of apoptotic induction <ref type="bibr" target="#b71">(72)</ref>.</s><s>Further studies are warranted to examine whether inhibition of Na + /K + -ATPase is the main target structure for induction of apoptosis.</s></p><p><s>Moreover, several cardiac glycosides are known to be potent P-glycoprotein inhibitors with low resistance indices in multidrug resistant P-glycoprotein-overexpressing cells <ref type="bibr" target="#b36">(37,</ref><ref type="bibr" target="#b72">73,</ref><ref type="bibr" target="#b73">74)</ref>.</s><s>Overexpression of the ABC transporter P-glycoprotein is responsible for classical MDR, by extruding chemotherapeutics to the outside of the cell.</s><s>Thus, cardiac glycosides with the capability of modulating P-glycoprotein, represent a significant source of alternatives in cancer treatment.</s><s>Mahringer et al. analysed the potential of P-glycoprotein inhibition by 57 compounds used in Chinese medicine combined with inhibition of cancer cell population growth.</s><s>Among these, bufalin was identified as a potent inhibitor without any cross-resistance, whereas proscillaridin inhibited Pglycoprotein with low cross-resistance.</s><s>Resibufogenin interestingly revealed collateral sensitivity in drug resistant CEM/ADR5000 cells <ref type="bibr" target="#b73">(74)</ref>.</s><s>In that study, microRNA expression experimentation revealed an MDR-independent cytotoxic effect for the analysed bufadienolides, except for resibufogenin.</s><s>Some theories on the mechanism of inhibition are mentioned below.</s><s>On the one hand cardiac glycosides can act as transport-independent inhibitors of P-glycoprotein-like cyclosporine A. On the other hand, it has been shown that they are able to inhibit stimulated P-glycoprotein ATPase activity slightly, despite acting as substrates for P-glycoprotein <ref type="bibr" target="#b72">(73)</ref>.</s><s>To gain more insight into the details of the mechanisms and the role of P-glycoprotein for our compounds, further studies need to be performed.</s></p><p><s>The results from the in vivo studies of, for example ouabain and bufalin, and clinical trials with digitoxin and digoxin, support the idea that therapeutic potential of these drugs should be further evaluated in cancer patients.</s><s>To counteract chemotherapeutic resistance, a combination of polychemotherapy with novel strategies is indispensable for osteosarcoma therapy.</s><s>In our study, we provide a first hint for cardiac glycosides as anti-cancer drugs for osteosarcoma treatment.</s><s>We have been able to show cell population growth inhibition, not only for common cardiac glycosides like ouabain, digoxin and digitoxin, but also for proscillaridin A, evomonoside and arenobufagin A. Our findings suggest that these cardiac glycosides are promising candidates for combined therapy with classical chemotherapeutic agents, to achieve potential synergism of effectiveness in treatment, and to overcome resistance to apoptosis in patients currently with dismal prognoses.</s><s>Thus, the therapeutic potential of steroid glycosides in combination with cytostatics must be further evaluated in vivo.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Inhibition of cell population growth of steroid glycoside-treated cells.</s><s>143B cells were treated with a range of steroid glycoside concentrations (0.05-10 lM) for 24 h.</s><s>Cell counts were analysed via CASY ® Counter.</s><s>Eighteen of 20 steroid glycosides were able to inhibit cell proliferation in a concentration-dependent manner (n = 3).</s></p></div></figDesc><graphic coords="4,228.19,71.83,309.24,348.53" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Apoptotic induction in 143B cells by steroid glycosides.</s><s>Cells were incubated with depicted concentrations of steroid glycosides for 24 h.</s><s>After treatment, induction of apoptosis was analysed using annexin V-APC and propidium iodide (PI).</s><s>Values are given as percentages of annexin-positive cells AESD.</s><s>Seventeen of the 20 cardiac glycosides increased percentages of annexin V-positive cells in a dose-dependent manner (n = 3).</s><s>Asterisk represents statistically significant differences compared to control group (*P &lt; 0.05, **P &lt; 0.001).</s></p></div></figDesc><graphic coords="5,58.11,71.83,309.02,346.96" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Steroid glycosides induced mitochondrial membrane depolarization.</s><s>Cells were treated with the most effective steroid glycosides for 24 h and mitochondrial membrane potential was evaluated using fluorescent dye JC-1 and flow cytometry.</s><s>Values of mitochondrial permeability transition are given as percentages of cells with low MMP AESD (n = 3).</s><s>Asterisk represents statistically significant differences compared to control group (*P &lt; 0.05).</s></p></div></figDesc><graphic coords="5,60.95,437.87,476.64,114.11" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. Apoptotic induction took place after 6 h incubation.</s><s>Cells were incubated with described concentrations of proscillaridin A, evomonoside and arenobufagin for 6, 16 or 24 h.</s><s>After incubation, apoptotic level and loss of mitochondrial membrane potential were analysed as shown previously.</s><s>Early cytotoxicity was measured after 4 h incubation, by LDH release assay.</s><s>There was no relevant induction of LDH release after 4 h by the three steroid glycosides.</s><s>(n = 3).</s><s>Asterisk represents statistically significant differences compared to control group (*P &lt; 0.05, **P &lt; 0.001).</s></p></div></figDesc><graphic coords="6,59.81,71.83,476.27,376.56" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 5 .</head><label>5</label><figDesc><div><p><s>Figure 5. Activation of caspases -8 and -9 in glycoside-induced apoptosis.</s><s>(a) Cells were treated with depicted glycosides and activity of caspases -8 and -9 were analysed by FITC-LEHD and FITC-IETD and flow cytometry after 24 h; AESD, n = 3.</s><s>(b) Cells were treated with proscillaridin, evomonoside or arenobufagin for 24 h in the presence or absence of 100 lM Z-VAD-fmk.</s><s>Effects of caspase inhibitor were analysed using annexin V/propidium iodide staining and flow cytometry, AESD, n = 3. Asterisk represents statistically significant differences compared to control group (*P &lt; 0.05).</s></p></div></figDesc><graphic coords="7,60.95,71.83,476.32,251.90" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Overview of used cardiac glycosides</s></p></div></figDesc><table><row><cell>Drug</cell><cell>Originated from</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">© 2015 John Wiley &amp; Sons LtdCell Proliferation, 48, 600-610</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head><p><s>Additional Supporting Information may be found in the online version of this article: Fig. <ref type="figure">S1</ref> Apoptotic induction in U2OS cells.</s><s>A. U2OS were incubated with depicted concentrations of steroid glycosides for 24 h.</s><s>After treatment, apoptotic induction was analysed with annexin V-APC and propidium iodide (PI).</s><s>Values are given as percentages of annexin-positive cells AESD.</s><s>B. Mitochondrial membrane potential was evaluated using fluorescent dye JC-1 and flow cytometry.</s><s>Values of mitochondrial permeability transition are given as percentages of cells with low MMP AESD (n = 3).</s><s>Asterisk represents statistically significant differences compared to control group (*P &lt; 0.05, **P &lt; 0.001).</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program</title>
		<author>
			<persName><forename type="first">L</forename><surname>Mirabello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Troisi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Savage</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="1531" to="1543" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Nooij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Whelan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Sydes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Grimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Hogendoorn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="112" to="128" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Ritter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Bielack</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Osteosarcoma. Ann. Oncol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="320" to="325" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Bufadienolides from animal and plant sources</title>
		<author>
			<persName><forename type="first">L</forename><surname>Krenn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kopp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Phytochemistry</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1" to="29" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Therapeutic and toxic effects of digitalis: William Withering, 1785</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Bessen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Emerg. Med</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="243" to="248" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Cardiac glycosides as novel cancer therapeutic agents</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Newman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Pawlus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">I</forename><surname>Block</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Interv</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="36" to="49" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Ouabain -the insulin of the heart</title>
		<author>
			<persName><forename type="first">H</forename><surname>Furstenwerth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Clin. Pract</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="1591" to="1594" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Novel therapeutic applications of cardiac glycosides</title>
		<author>
			<persName><forename type="first">I</forename><surname>Prassas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Diamandis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Drug Discov</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="926" to="935" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Bufadienolides and their antitumor activity</title>
		<author>
			<persName><forename type="first">H</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Popescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Prod. Rep</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="953" to="969" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Na(+), K(+)-ATPase: the new face of an old player in pathogenesis and apoptotic/hybrid cell death</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Yu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="1601" to="1609" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Regulation and critical role of potassium homeostasis in apoptosis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Yu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prog. Neurobiol</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="363" to="386" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">On the mechanism of ionic regulation of apoptosis: would the Na+/K + -ATPase please stand up?</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Panayiotidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Bortner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cidlowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Physiol. (Oxf.)</title>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="page" from="205" to="215" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Ouabain-induced perturbations in intracellular ionic homeostasis regulate death receptor-mediated apoptosis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Panayiotidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Franco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Bortner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cidlowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Apoptosis</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="834" to="849" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Cardiac glycosides stimulate Ca2 + increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Mcconkey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Nutt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Z</forename><surname>Ozel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Newman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="3807" to="3812" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Cardiotonic steroids-mediated Na+/K + -ATPase targeting could circumvent various chemoresistance pathways</title>
		<author>
			<persName><forename type="first">T</forename><surname>Mijatovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Planta Med</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="189" to="198" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lefranc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mijatovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kondo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sauvage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Roland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Debeir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosurgery</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="221" to="222" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers</title>
		<author>
			<persName><forename type="first">T</forename><surname>Mijatovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Roland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Van Quaquebeke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nilsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mathieu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Van Vynckt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Pathol</title>
		<imprint>
			<biblScope unit="volume">212</biblScope>
			<biblScope unit="page" from="170" to="179" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">The Na+/K + -ATPase is the Achilles heel of multidrug-resistant cancer cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Mijatovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Jungwirth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Heffeter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Hoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dornetshuber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Lett</title>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="page" from="30" to="34" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells</title>
		<author>
			<persName><forename type="first">K</forename><surname>Winnicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bielawski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bielawska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Miltyk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch. Pharm. Res</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1216" to="1224" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Antiproliferative activity of derivatives of ouabain, digoxin and proscillaridin A in human MCF-7 and MDA-MB-231 breast cancer cells</title>
		<author>
			<persName><forename type="first">K</forename><surname>Winnicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bielawski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bielawska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Surazynski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol. Pharm. Bull</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1131" to="1140" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Platz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yegnasubramanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Chong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Shim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Kenfield</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Discov</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="68" to="77" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Bagrov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Shapiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">V</forename><surname>Fedorova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol. Rev</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="9" to="38" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Digitoxin medication and cancer; case control and internal dose-response studies</title>
		<author>
			<persName><forename type="first">J</forename><surname>Haux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Klepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Spigset</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tretli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Cancer</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Digoxin-like immunoreactive factors induce apoptosis in human acute T-cell lymphoblastic leukemia</title>
		<author>
			<persName><forename type="first">K</forename><surname>Ihenetu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Qazzaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Crespo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fernandez-Botran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Valdes</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin. Chem</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="1315" to="1322" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Ex vivo activity of cardiac glycosides in acute leukaemia</title>
		<author>
			<persName><forename type="first">H</forename><surname>Hallbook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Felth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Eriksson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fryknas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bohlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Larsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<date type="published" when="2011">2011. e15718</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lopez-Lazaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Pastor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Azrak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ayuso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Austin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cortes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Nat. Prod</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="1642" to="1645" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Apoptotic signaling in bufalin-and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Kan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Pu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jea</forename><surname>Chien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Sci</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="2467" to="2476" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas-and mitochondria-mediated pathways</title>
		<author>
			<persName><forename type="first">F</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Inagaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kokudo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Sci</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="951" to="958" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Rapid structural identification of cytotoxic bufadienolide sulfates in toad venom from Bufo melanosticus by LC-DAD-MS(n) and LC-SPE-NMR</title>
		<author>
			<persName><forename type="first">H</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zehl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kaehlig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stuppner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ybl</forename><surname>Moreno</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Nat. Prod</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="603" to="608" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Comparison of toad venoms from different Bufo species by HPLC and LC-DAD-MS/MS</title>
		<author>
			<persName><forename type="first">H</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zehl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leitner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kopp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Ethnopharmacol</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="368" to="376" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Bufadienolides from Urginea maritima sensu strictu</title>
		<author>
			<persName><forename type="first">L</forename><surname>Krenn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ferth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Robien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kopp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Planta Med</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="560" to="565" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Structure-activity relationship analysis of bufadienolide-induced in vitro growth inhibitory effects on mouse and human cancer cells</title>
		<author>
			<persName><forename type="first">Ybl</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Urban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gelbcke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Dufrasne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Nat. Prod</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="1078" to="1084" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Bufadienolides from Urginea hesperia</title>
		<author>
			<persName><forename type="first">L</forename><surname>Krenn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jambrits</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kopp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Planta Med</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="227" to="232" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">New cardenolides from Convallaria majalis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Kopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kubelka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Planta Med</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="195" to="202" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">The constituents of Convallaria. II. The isolation of desglucocheirotoxin</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Thoma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kikuchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Yakugaku Zasshi</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="1320" to="1323" />
			<date type="published" when="1962">1962</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">A new development of triterpene acid-containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Delebinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jaeger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kemnitz-Hassanin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Henze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">N</forename><surname>Lode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Seifert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Prolif</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="176" to="187" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Johansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lindholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gullbo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Larsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bohlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Claeson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anticancer Drugs</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="475" to="483" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bielawski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Winnicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bielawska</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol. Pharm. Bull</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1493" to="1497" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo</title>
		<author>
			<persName><forename type="first">E</forename><surname>Denicolai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Baeza-Kallee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tchoghandjian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Carre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Colin</forename><forename type="middle">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="10934" to="10948" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450</title>
		<author>
			<persName><forename type="first">C</forename><surname>Cerella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gaigneaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Radogna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Viry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chateauvieux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Death Dis</title>
		<imprint>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">e1782</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Ouabain downregulates Mcl-1 and sensitizes lung cancer cells to TRAIL-induced apoptosis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Chanvorachote</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pongrakhananon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am. J. Physiol. Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">304</biblScope>
			<biblScope unit="page" from="C263" to="C272" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Monosaccharide digitoxin derivative sensitize human non-small cell lung cancer cells to anoikis through Mcl-1 proteasomal degradation</title>
		<author>
			<persName><forename type="first">V</forename><surname>Pongrakhananon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Stueckle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>O'doherty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Z</forename><surname>Dinu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chanvorachote</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="23" to="35" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Proliferation and apoptosis of HeLa cells induced by in vitro stimulation with digitalis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ramirez-Ortega</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Maldonado-Lagunas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Melendez-Zajgla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Carrillo-Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pastelin-Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Picazo-Picazo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">534</biblScope>
			<biblScope unit="page" from="71" to="76" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Cardiac glycoside ouabain induces autophagic cell death in non-small cell lung cancer cells via a JNK-dependent decrease of Bcl-2</title>
		<author>
			<persName><forename type="first">A</forename><surname>Trenti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Grumati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cusinato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Orso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bonaldo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Trevisi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="197" to="209" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Inhibitory effects of digitalis the proliferation androgen dependent and independent prostate cancer cells</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Yeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Kan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Urol</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="page" from="1937" to="1942" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Ouabain activates signaling pathways associated with cell death in human neuroblastoma</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kulikov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Eva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Kirch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boldyrev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Scheiner-Bobis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim. Biophys. Acta</title>
		<imprint>
			<biblScope unit="volume">1768</biblScope>
			<biblScope unit="page" from="1691" to="1702" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells</title>
		<author>
			<persName><forename type="first">R</forename><surname>Pezzani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rubin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Redaelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Radu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Barollo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Cicala</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr. J</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="41" to="53" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Quiescence and gammaH2AX in neuroblastoma are regulated by ouabain/Na, K-ATPase</title>
		<author>
			<persName><forename type="first">H</forename><surname>Hiyoshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Abdelhady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Segerstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sveinbjornsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nuriya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Lundgren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="1807" to="1815" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tailler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Senovilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lainey</forename><forename type="middle">E</forename><surname>Thepot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Metivier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="3536" to="3546" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Mawji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Anyiwe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Venugopal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="2739" to="2747" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Is digitalis a therapy for breast carcinoma?</title>
		<author>
			<persName><forename type="first">B</forename><surname>Stenkvist</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncol. Rep</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="493" to="496" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Evidence of a modifying influence of heart glucosides on the development of breast cancer</title>
		<author>
			<persName><forename type="first">B</forename><surname>Stenkvist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bengtsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Eklund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Eriksson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Holmquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nordin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anal. Quant. Cytol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="49" to="54" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Westman-Naeser S (1979) Cardiac glycosides and breast cancer</title>
		<author>
			<persName><forename type="first">B</forename><surname>Stenkvist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bengtsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Eriksson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Holmquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nordin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">563</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Cao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1331" to="1342" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Arenobufagin, a compound in toad venom, blocks Na(+)-K+ pump current in cardiac myocytes</title>
		<author>
			<persName><forename type="first">Cruz</forename><surname>Jdos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Matsuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">239</biblScope>
			<biblScope unit="page" from="223" to="226" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway</title>
		<author>
			<persName><forename type="first">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="1251" to="1260" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Bufalin induces apoptosis in osteosarcoma U-2OS and U-2OS methotrexate 300-resistant cell lines in vitro</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Q</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Jia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">B</forename><surname>Xie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Zhonghua Zhong Liu Za Zhi</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="734" to="738" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Proteomics research of bufalin-induced apoptosis in osteosarcoma cell lines</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">B</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Wen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Q</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Zou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Zhongguo Zhong Yao Za Zhi</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="2739" to="2743" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Bufalin inhibits the differentiation and proliferation of human osteosarcoma cell line hMG63-derived cancer stem cells</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tumour Biol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1075" to="1082" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Chueh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ. Toxicol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="21" to="29" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Bufalin inhibited the growth of human osteosarcoma MG-63 cells via down-regulation of Bcl-2/Bax and triggering of the mitochondrial pathway</title>
		<author>
			<persName><forename type="first">D</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Bi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tumour Biol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="4885" to="4890" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Q</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jin</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Pharmacol. Sin</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="712" to="720" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Critical role of heat shock protein 27 in bufalin-induced apoptosis in human osteosarcomas: a proteomic-based research</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">B</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Q</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Wen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">H</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Zou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e47375</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation. Free Radic</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">Y</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol. Med</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="1365" to="1375" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Watabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Masuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nakajo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nakaya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="779" to="787" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Ion channels and apoptosis in cancer</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Bortner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cidlowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Philos. Trans. R. Soc. Lond. B Biol. Sci</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<date type="published" when="2014">2014. 20130104</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">The role of apoptotic volume decrease and ionic homeostasis in the activation and repression of apoptosis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Bortner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cidlowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pflugers Arch</title>
		<imprint>
			<biblScope unit="volume">448</biblScope>
			<biblScope unit="page" from="313" to="318" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Regulation of cell death: the calcium-apoptosis link</title>
		<author>
			<persName><forename type="first">S</forename><surname>Orrenius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zhivotovsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nicotera</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="552" to="565" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Inactivation of Src-to-ezrin pathway: a possible mechanism in the ouabain-mediated inhibition of A549 cell migration</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Ryu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomed. Res. Int</title>
		<imprint>
			<biblScope unit="page">537136</biblScope>
			<date type="published" when="2015">2015. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Death of ouabain-treated renal epithelial cells: evidence for p38 MAPK-mediated Na (i) (+)/K (i) (+)-independent signaling</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Akimova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Lopina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Rubtsov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gekle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tremblay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hamet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Apoptosis</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1266" to="1273" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Investigation of mechanism of p38 MAPK activation in renal epithelial cell from distal tubules triggered by cardiotonic steroids</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Akimova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">D</forename><surname>Lopina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Rubtsov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hamet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Orlov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry (Mosc)</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="971" to="978" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Reevesioside F induces potent and efficient anti-proliferative and apoptotic activities through Na(+)/K(+)-ATPase alpha3 subunit-involved mitochondrial stress and amplification of caspase cascades</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Leu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="1564" to="1575" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Identification of new P-glycoprotein inhibitors derived from cardiotonic steroids</title>
		<author>
			<persName><forename type="first">M</forename><surname>Zeino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Paulsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zehl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Urban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Efferth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="11" to="24" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mahringer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Karamustafa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Klotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">B</forename><surname>Konkimalla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Genomics Proteomics</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="191" to="205" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
